142 related articles for article (PubMed ID: 35296768)
1. Integrative analysis reveals the functional implications and clinical relevance of pyroptosis in low-grade glioma.
Shen L; Li Y; Li N; Zhao Y; Zhou Q; Shen L; Li Z
Sci Rep; 2022 Mar; 12(1):4527. PubMed ID: 35296768
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Pyroptosis-Associated in Molecular Classification, Immunity and Prognostic of Glioma.
Chen P; Li Y; Li N; Shen L; Li Z
Front Genet; 2021; 12():781538. PubMed ID: 35069683
[TBL] [Abstract][Full Text] [Related]
3. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
4. Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients.
Tanzhu G; Li N; Li Z; Zhou R; Shen L
Front Oncol; 2022; 12():779168. PubMed ID: 35237509
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors.
Lai G; Li K; Deng J; Liu H; Xie B; Zhong X
J Healthc Eng; 2022; 2022():8704127. PubMed ID: 35535221
[TBL] [Abstract][Full Text] [Related]
6. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma.
Huang Q; Li J; Mo L; Zhao Y
World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369
[TBL] [Abstract][Full Text] [Related]
7. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma.
Wang W; Wu F; Zhao Z; Wang KY; Huang RY; Wang HY; Lan Q; Wang JF; Zhao JZ
CNS Neurosci Ther; 2018 Oct; 24(10):957-966. PubMed ID: 29577647
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue.
Ma S; Zhao H; Wang F; Peng L; Zhang H; Wang Z; Jiang F; Zhang D; Yin M; Li S; Huang J; Liu Z; Tao S
Aging (Albany NY); 2023 Mar; 15(5):1628-1651. PubMed ID: 36917093
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
11. Development of a Prognostic Model of Glioma Based on Pyroptosis-Related Genes.
Niu X; Cheng R; Wang Y; Chen J; Wang C; Ji H
World Neurosurg; 2022 Feb; 158():e929-e945. PubMed ID: 34861452
[TBL] [Abstract][Full Text] [Related]
12. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
Tan Y; Lu L; Liang X; Chen Y
World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
[TBL] [Abstract][Full Text] [Related]
13. Bulk and Single-Cell Transcriptome Analyses Revealed That the Pyroptosis of Glioma-Associated Macrophages Participates in Tumor Progression and Immunosuppression.
Li L; Wu L; Yin X; Li C; Hua Z
Oxid Med Cell Longev; 2022; 2022():1803544. PubMed ID: 36199426
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
15. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
[TBL] [Abstract][Full Text] [Related]
16. Predicting the prognosis of glioma by pyroptosis-related signature.
Chao B; Jiang F; Bai H; Meng P; Wang L; Wang F
J Cell Mol Med; 2022 Jan; 26(1):133-143. PubMed ID: 34816605
[TBL] [Abstract][Full Text] [Related]
17. A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma.
Zhong J; Liu J; Huang Z; Zheng Y; Chen J; Ji J; Chen T; Ke Y
Front Genet; 2022; 13():1026192. PubMed ID: 36353102
[No Abstract] [Full Text] [Related]
18. A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma.
Yang Z; Chen Z; Wang Y; Wang Z; Zhang D; Yue X; Zheng Y; Li L; Bian E; Zhao B
Front Oncol; 2022; 12():717926. PubMed ID: 35433410
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of pyroptosis regulation patterns and their influence on tumor immune microenvironment and patient prognosis in glioma.
Fan T; Wan Y; Niu D; Wang B; Zhang B; Zhang Z; Zhang Y; Gong Z; Zhang L
Discov Oncol; 2022 Mar; 13(1):13. PubMed ID: 35274175
[TBL] [Abstract][Full Text] [Related]
20. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
